H. R. 3584, Laboratory Access for Beneficiaries Act.

Summary: To amend title XVIII of the Social Security Act to provide for certain amendments relating to reporting requirements with respect to clinical diagnostic laboratory tests, and for other purposes. (Cosponsors, Bipartisan)

ANGIE CRAIG’S POSITION:  Representative Craig Cosponsored the bill on 12/09/19.


STATUS: Introduced 6/27/19 by Rep. Peters, Scott H. [D-CA-52] .


  • In the first round of private-market rate collection in 2017, CMS prohibited essentially all hospital laboratories from reporting data to CMS, even though hospital labs make up approximately 26 percent of Clinical Laboratory Fee Schedule (CLFS) spending. While CMS amended the PAMA regulation in 2018 to require more hospital laboratories to collect and report data, few hospital labs are aware of the requirement. As a result, many hospitals that are now required to report have very little time to build the necessary data systems to meet the new requirement. Labs that fail to comply with the data reporting requirement may be subject to civil monetary penalties of up to $10,000 per day for each misrepresentation or omission. The Laboratory Access for Beneficiaries Act (LAB Act, H.R. 3584), introduced in the U.S. House of Representatives by Reps. Peters (D-CA), Bilirakis (R-FL), Pascrell (D-NJ), Holding (R-NC), Schrader (D-OR) and Hudson (R-NC), would take an important step by providing a one-year delay of PAMA data reporting activities. Suspending data reporting in 2020 accomplishes two critical goals:
    • Allowing a more representative share of labs to report private market data; and
    • Providing valuable time for stakeholders and policymakers to determine how to reform PAMA and ensure a truly market-based system that will protect Medicare beneficiary access. (Source: American Clinical Laboratory Association)


Link to the text of the bill.

Link to bill information (support and opposition) on Countable.